Random42 Partner with MedCity for BioJapan 2018

The annual biotech partnering conference has played an important role in facilitating interaction between Japanese and global companies, stimulating new business opportunities for almost two decades. Over 900 organizations from around 30 countries are expected to participate in the event, to hold an anticipated 9,000 business meetings over the course of the three days.

Random42 have partnered with MedCity to attend the event as part of the UK delegation, which aims to showcase the UK’s ecosystem and forge collaborations with Japanese pharma and academia.

Join the team at booth D28 to experience cutting-edge and immersive technology, including, the latest in scientific animation, scientific virtual reality, augmented reality and interactive experiences.

In advance of BioJapan, Random42 will also be joining MedCity and the Northern Health Science Alliance at a UK Life Sciences Symposium in Tokyo, which they are co-hosting with LINK-J. Leading UK health scientists, universities and national research institutions will provide insight into the UK life sciences sector, and their work in ageing, gene editing and artificial intelligence. Register for this event here.

For more information about BioJapan please visit: www.medcityhq.com/2018/09/25/were-off-to-biojapan

For more information on Random42’s capabilities please see their Digital Brochure or visit their website.

About Random42:

A - 51 Great Marlborough Street, London, W1F 7JT
E - info@random42.com
T - +44-(0)-20-7734-6001
W - www.random42.com

Random42 Scientific Communication is a leading scientific communication studio specialising in medical animation and education, scientific virtual reality, interactive and visually engaging solutions for global pharmaceutical and biotechnology companies. In their 26-year history they have produced core digital assets for over 650 product launches to date and won over 150 industry awards.

Earlier this year Random42 were honoured with a Queen’s Award for excellence in International Trade. The globally recognised awards have a long history of celebrating exceptional UK businesses and are considered the most prestigious business awards in the UK. The category of International Trade recognises businesses who have demonstrated substantial international growth in overseas earnings and commercial success within their sector.

About MedCity:

MedCity exists to promote and grow life sciences investment, entrepreneurship and industry across the greater south east of England.

Supported by the Mayor of London, the London Academic Health Science Centres, and research institutes and life sciences organisations across the region, MedCity acts as a front door to the sector. From drug discovery to devices, diagnostics and digital health, MedCity works with industry, researchers and investors looking for partners, infrastructure and expertise across the greater south east of England. We facilitate connectivity across industry, academia and the health service.

MedCity raises awareness globally of the UKs rich life sciences ecosystem, which has more than 3,400 life sciences companies, four of the world’s top ten universities, 19 of the top 20 global pharmaceutical companies and world-class research centres including The Francis Crick Institute, Harwell Oxford, and the Wellcome Sanger Institute.